Third Harmonic Bio, Inc. Banner Image

Third Harmonic Bio, Inc.

  • Ticker THRD
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Third Harmonic Bio, Inc. Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases through the development of a novel highly selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Early clinical studies demonstrate that KIT inhibition has the potential to revolutionizeMore the treatment of a broad range of mast-cell-mediated inflammatory diseases, and that a titratable, oral, intracellular small molecule inhibitor may provide the optimal therapeutic profile against this target.
Third Harmonic Bio, Inc.

Most Recent Annual Report

Third Harmonic Bio, Inc.
MOST RECENT 2022 Annual Report and Form 10K
Third Harmonic Bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!